SoliCGM Synergy: Soliqua’s Synchronized Impact on T2DM CGM Dynamics Therapy
Join Dr. Viral Shah as he explores the use of CGM metrics to assess clinical outcomes in Type 2 Diabetes patients receiving Iglarlixi. This insightful discussion sheds light on the transformative role of Soliqua in diabetes management, providing valuable perspectives for healthcare professionals. Enhance your knowledge and improve patient care with this engaging talk.
Related articles
MAT-BH-2400350/v1/July 2024